Electronic medical records and doctor/patient communication
April 2, 2015 |
View from the US: When I talk to family members or friends who are physicians these days, I hear a lot of complaints.
What seems to get US doctors I talk to most agitated is an aspect of Obamacare that gets relatively little attention outside the healthcare community: the “forced” conversion of medical practices to electronic medical records (EMR).
Under legislation signed in 2009, physicians were given a January 2015 deadline to convert to EMR and show “meaningful use” of these systems or face lower reimbursement rates on Medicare physician fees – a penalty of 1 percent of Medicare payments, increasing to 2 percent in 2016 and 3 percent in 2017. To help offset the cost of EMR conversion, the federal government is offering individual practitioners up to $44,000 in incentive payments under the American Recovery and Reinvestment Act. With both a carrot and a stick in place, physician practices, large and small, have been converting en masse.
For many US physician practices, implementing EMR software and converting paper patient records to electronic form has been massively disruptive, as well as costly. My own primary care practice, a small physician group, cut back on the number of patients seen per day for several months while their doctors and staff learned the new system.
Even with the financial and administrative challenges, what some doctors find to be the most difficult aspect of the conversion to EMR is the way it impacts the daily practice of medicine by changing how they communicate with patients, and thus altering the doctor-patient relationship. With increasing time pressures, some clinicians feel they need to type into their computer or tablet while talking to patients, their face buried in the screen. Many find this takes their focus away from what the patient is saying, and leads them to miss picking up on some cues, or gaining a more holistic understanding of the patient. On the other hand, some believe the greater access to information through the EMR system, and elimination of the need to scan through paper records, improves patient care.
A 2008 study conducted by the Center for Studying Health System Change found EMR systems both help and hinder communication between doctors and patients, as well as clinician-clinician interactions. As system designs improve and physicians gain increasing familiarity with the technology, the positives should outpace the negatives. Certainly, for the new generation of physicians (like my daughter, who is a third year medical student), who are learning the practice of medicine with these tools, the use of EMR should be second nature.
As a market researcher, who has seen MR evolve from largely face-to-face to largely web-based, I wonder if there are parallels for our industry… Is our evolving technology promoting or hindering engaging in dialogue with respondents? It certainly is possible for researchers to be distracted by the “latest and greatest” technological innovation in MR. The key is to be able to leverage our technology to gain richer insights and understanding, not simply more data.
Research Partnership is one of the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical industry, we use our expertise and experience to deliver intelligent, tailor-made solutions. We provide strategic recommendations that go beyond research, helping our clients to answer their fundamental business challenges. Find out more here: http://bit.ly/1FbCHZG
This content was provided by Research Partnership
Company Details
Latest Content from Research Partnership
Research Partnership is UK’s fastest growing healthcare market research specialist
The latest league tables for the UK market research industry have just been released and reveal Research Partnership to be the fastest growing healthcare market research specialist for 2014.With turnover...
Emerging Markets: Your Essential Guide
Using our combined knowledge and years of experience of working in these territories, our experts have produced an essential guide to help address some of the core challenges for conducting market...
Free Thinking: From promise to practice: immuno-oncology in action
This white paper explores the global outlook for new immunotherapy products, referencing key opinion leaders and payers to investigate how these products are faring both clinically and financially. Immuno-oncology therapies that...
Exploring the Opportunity For Halal In Healthcare
Published in Medical Marketing & Media November 2015
Case study: Opportunity Assessment for a Rare Disease Product in Emerging Markets
Using in-depth-interviews to determine how to maximise the commercial opportunities in different emerging markets
12 Challenges Big Pharma Faces in China
Published in eyeforpharma 16 November by Rachel Howard
Using mobile “diary” research to capture patient-generated insights in COPD
Our latest case study demonstrates how a mobile app methodology was used to deliver key insights into issues faced by COPD patients
Biosimilars in 2018: EU doctors’ perceptions of RA drug market
Published in pharmaphorum October 2015 by Laurent Chanroux
Webinar: Understanding the Patient Journey in China 2015
Utilising local knowledge and detailed case studies, this webinar examines the likely impact on the patient journey and consider the possible implications for market researchers.
Understanding Patient Willingness to Pay
Published in eyeforpharma 12 October by Rachel Howard